Adicet Bio Inc (ACET NASDAQ) stock market data APIs
$6.9519
0.05(0.7%)
as of March 20, 2026
Try our APIs with
free plan!
Adicet Bio Inc Financial Data Overview
Price chart is built with
Anychart
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Prev. Close
6.9519
Open
7.0019
High
7.1759
Low
6.879
52 wk Range
6.4066-17.4384
Market Cap
66 432 K
Shares Outstanding
9 596 K
EPS
-2.94
Beta
1.613
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Adicet Bio Inc data using free add-ons & libraries
Get Adicet Bio Inc Fundamental Data
Adicet Bio Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -115 733 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-05
- EPS/Forecast: -0.1931
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Adicet Bio Inc News
New
Adicet Bio To Implement 1-for-16 Reverse Stock Split On December 30
(RTTNews) - Adicet Bio (ACET) said its board has approved a one-for-16 reverse stock split of the company's common stock as part of efforts to regain compliance with Nasdaq's minimum bid price require...
Adicet Bio Announces Reverse Stock Split
REDWOOD CITY, Calif., December 26, 2025--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for...
Nutex Health Soars 21% After Hours On Revenue Surge; Biotech Peers Join Tuesday Gainers
(RTTNews) - Several small-cap biotech and pharma names posted notable gains in Tuesday's after-hours trading session, with Nutex Health standing out as the most significant mover following its quarter...
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Exact Sciences (EXAS) is a stock that can certainly grab the attention of many inves...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
